Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TOMMERUP AUTORISEREDE FYSIOTERAPI OG OSTEOPATI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   1.0% 0.9% 1.4% 1.6% 1.4% 1.2% 10.9% 10.9%   Credit score (0-100)   87 90 78 73 78 81 22 22   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   144.3 275.0 13.3 4.1 19.6 88.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,924 3,227 3,225 4,230 4,082 5,107 0.0 0.0   EBITDA   1,289 1,439 1,192 869 968 1,374 0.0 0.0   EBIT   836 1,256 988 679 772 1,160 0.0 0.0   Pre-tax profit (PTP)   635.0 1,088.0 688.0 446.0 714.0 830.9 0.0 0.0   Net earnings   492.0 844.0 534.0 347.0 550.0 635.4 0.0 0.0   Pre-tax profit without non-rec. items   635 1,088 688 446 714 831 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   6,884 6,839 6,726 6,537 6,748 6,799 0.0 0.0   Shareholders equity total   2,068 2,492 714 836 1,156 1,551 1,131 1,131   Interest-bearing liabilities   5,007 4,578 6,217 6,078 6,063 5,834 0.0 0.0   Balance sheet total (assets)   7,551 7,573 7,571 7,592 7,631 7,937 1,131 1,131   Net Debt   4,944 4,560 6,106 5,864 6,014 5,729 -1,131 -1,131     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,924 3,227 3,225 4,230 4,082 5,107 0.0 0.0   Gross profit growth   2.2% 10.4% -0.1% 31.2% -3.5% 25.1% -100.0% 0.0%   Employees   4 4 5 7 7 7 0 0   Employee growth %   0.0% 0.0% 25.0% 40.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   7,551 7,573 7,571 7,592 7,631 7,937 1,131 1,131   Balance sheet change%   -1.6% 0.3% -0.0% 0.3% 0.5% 4.0% -85.7% 0.0%   Added value   1,289.0 1,439.0 1,192.0 869.0 962.0 1,374.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -833 -228 -317 -379 15 -162 -6,799 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   28.6% 38.9% 30.6% 16.1% 18.9% 22.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   11.0% 16.6% 13.0% 9.0% 12.4% 14.9% 0.0% 0.0%   ROI %   11.7% 17.7% 14.1% 9.8% 13.3% 15.9% 0.0% 0.0%   ROE %   24.2% 37.0% 33.3% 44.8% 55.2% 46.9% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   27.4% 32.9% 9.4% 11.0% 15.1% 19.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   383.6% 316.9% 512.2% 674.8% 621.3% 416.9% 0.0% 0.0%   Gearing %   242.1% 183.7% 870.7% 727.0% 524.5% 376.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.9% 3.5% 5.6% 3.8% 3.7% 5.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.3 0.4 0.4 0.4 0.3 0.4 0.0 0.0   Current Ratio   0.3 0.4 0.5 0.4 0.4 0.4 0.0 0.0   Cash and cash equivalent   63.0 18.0 111.0 214.0 49.0 104.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -1,488.0 -918.0 -1,026.0 -1,458.0 -1,502.0 -1,745.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   322 360 238 124 137 196 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   322 360 238 124 138 196 0 0   EBIT / employee   209 314 198 97 110 166 0 0   Net earnings / employee   123 211 107 50 79 91 0 0